Table 2 Details on number of tests, cases detected and proportion of cases treated or referred between 2018 and 2020
Project year | People tested n (column %) | Malaria cases detected n (row %) | Proportion of malaria cases that received treatment or were referred n (%) | |||
|---|---|---|---|---|---|---|
P. falciparum | P. vivax | ACTa | Referredb | Primaquinec | ||
2018 | 13,407 (17%) | 934 (42%) | 1264 (58%) | 1739 (79%) | 459 (21%) | 81 (9%) |
2019 | 33,300 (41%) | 314 (19%) | 1309 (81%) | 1499 (92%) | 124 (8%) | 159 (51%) |
2020 | 34,281 (42%) | 32 (6%) | 532 (94%) | 517 (92%) | 47 (8%) | 26 (81%) |
Overall | 80,988 (100%) | 1280 (30%) | 3105 (71%) | 3755 (86%) | 630 (14%) | 266 (21%) |